Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Heaton

Showing results (171-180 of 198) with videos related to

Pageof 20
Sort By:
Molecular Cancer Therapeutics|April 29, 2010
AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growthKyla M Grimshaw, Lisa-Jane K Hunter, Timothy A Yap, et al.
Gigascience|April 4, 2020
Continuous chromosome-scale haplotypes assembled from a single interspecies F1 hybrid of yak and cattleEdward S Rice, Sergey Koren, Arang Rhie, et al.
Plos Genetics|February 1, 2012
Reduced lentivirus susceptibility in sheep with TMEM154 mutationsMichael P Heaton, Michael L Clawson, Carol G Chitko-Mckown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumorsTimothy A Yap, Li Yan, Amita Patnaik, et al.
Molecular Ecology|January 18, 2023
Colonialism in South Africa leaves a lasting legacy of reduced genetic diversity in Cape buffaloLiam Quinn, Genís Garcia-Erill, Cindy Santander, et al.
F1000Research|April 29, 2024
Association of <i>ARRDC3</i> and <i>NFIA</i> variants with bovine congestive heart failure in feedlot cattleMichael P Heaton, Gregory P Harhay, Adam S Bassett, et al.
Molecular Cancer Therapeutics|December 31, 2010
Preclinical pharmacology, antitumor activity, and development of pharmacodynamic markers for the novel, potent AKT inhibitor CCT128930Timothy A Yap, Mike I Walton, Lisa-Jane K Hunter, et al.
BMC Veterinary Research|July 16, 2008
Prevalence of the prion protein gene E211K variant in U.S. cattleMichael P Heaton, John W Keele, Gregory P Harhay, et al.
The Journal of Heredity|February 17, 2021
A Reference Genome Assembly of American Bison, Bison bison bisonJonas Oppenheimer, Benjamin D Rosen, Michael P Heaton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosisRobert W Wilkinson, Rajesh Odedra, Simon P Heaton, et al.
Pageof 20

Showing results (171-180 of 198) with videos related to

Sort By:
Pageof 20
Molecular Cancer Therapeutics|April 29, 2010
AT7867 is a potent and oral inhibitor of AKT and p70 S6 kinase that induces pharmacodynamic changes and inhibits human tumor xenograft growthKyla M Grimshaw, Lisa-Jane K Hunter, Timothy A Yap, et al.
Gigascience|April 4, 2020
Continuous chromosome-scale haplotypes assembled from a single interspecies F1 hybrid of yak and cattleEdward S Rice, Sergey Koren, Arang Rhie, et al.
Plos Genetics|February 1, 2012
Reduced lentivirus susceptibility in sheep with TMEM154 mutationsMichael P Heaton, Michael L Clawson, Carol G Chitko-Mckown, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
First-in-man clinical trial of the oral pan-AKT inhibitor MK-2206 in patients with advanced solid tumorsTimothy A Yap, Li Yan, Amita Patnaik, et al.
Molecular Ecology|January 18, 2023
Colonialism in South Africa leaves a lasting legacy of reduced genetic diversity in Cape buffaloLiam Quinn, Genís Garcia-Erill, Cindy Santander, et al.
F1000Research|April 29, 2024
Association of <i>ARRDC3</i> and <i>NFIA</i> variants with bovine congestive heart failure in feedlot cattleMichael P Heaton, Gregory P Harhay, Adam S Bassett, et al.
Molecular Cancer Therapeutics|December 31, 2010
Preclinical pharmacology, antitumor activity, and development of pharmacodynamic markers for the novel, potent AKT inhibitor CCT128930Timothy A Yap, Mike I Walton, Lisa-Jane K Hunter, et al.
BMC Veterinary Research|July 16, 2008
Prevalence of the prion protein gene E211K variant in U.S. cattleMichael P Heaton, John W Keele, Gregory P Harhay, et al.
The Journal of Heredity|February 17, 2021
A Reference Genome Assembly of American Bison, Bison bison bisonJonas Oppenheimer, Benjamin D Rosen, Michael P Heaton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 19, 2007
AZD1152, a selective inhibitor of Aurora B kinase, inhibits human tumor xenograft growth by inducing apoptosisRobert W Wilkinson, Rajesh Odedra, Simon P Heaton, et al.
Pageof 20